Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
Leukemia & Lymphoma|January 29, 2019
The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosisRaffaella Marcheselli, Antonella Franceschetto, Stefano Sacchi, et al.Hematological Oncology|June 5, 2020
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphomaRaffaella Marcheselli, Alessia Bari, Tamar Tadmor, et al.Hematological Oncology|July 27, 2007
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern ItalyStefano Luminari, Marina Cesaretti, Ivan Rashid, et al.Leukemia & Lymphoma|September 16, 2011
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trialFortunato Morabito, Stefan Hohaus, Corrado Mammi, et al.Acta Oncologica (Stockholm, Sweden)|June 22, 2013
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based studyFrancesco Iachetta, Luca Reggiani Bonetti, Luigi Marcheselli, et al.European Journal of Haematology|April 23, 2010
The clinical and biological features of a series of immunophenotypic variant of B-CLLLilla Cro, Andrea Ferrario, Marta Lionetti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano LinfomiTeodoro Chisesi, Monica Bellei, Stefano Luminari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study databasePhilippe Solal-Céligny, Monica Bellei, Luigi Marcheselli, et al.Internal and Emergency Medicine|August 10, 2013
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasmsFederica Domati, Stefania Maffei, Shaniko Kaleci, et al.Acta Haematologica|November 8, 2016
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-UpAlessia Bari, Raffaella Marcheselli, Luigi Marcheselli, et al.Pageof 13